CONMED
CNMD | NYSE
$49.35
-$1.24 (-2.45%)
At close: Nov 16, 2026, 4:00 PM ET
$49.35
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:00 PM ET
CONMED Company Profile
Company profile explainedCompany Profile
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
Key Executives
| Name | Position |
|---|---|
| Patrick J. Beyer | President, Chief Executive Officer & Director |
| Richard Glaze | Chief Information Officer |
| Brent Lalomia | Executive VP of Regulatory Affairs, Quality Assurance, Clinical Affairs, Commercial Operations & IT |
| Curt R. Hartman | Special Advisor |
| Hollie Foust | Executive Vice President, General Counsel and Corporate Secretary |
| John E. Gallagher | Executive VP, CFO and Principal Financial & Accounting Officer |
| John Ferrell | Executive Vice President of Human Resources |
| Josep Lluis Llorens | Executive VP Global Supply Chain Management & Operations |
| Keith Seaton | Vice President of Compliance |
| Peter K. Shagory | Executive Vice President of Strategy & Corporate Development |
| Todd W. Garner | Advisor |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 28, 2026 | 10-Q | Quarterly Report |
| Oct 28, 2026 | 8-K | Current Report |
| Sep 10, 2026 | 4 | Filing |
| Jul 29, 2026 | 10-Q | Quarterly Report |
| Jul 29, 2026 | 8-K | Current Report |
| Jul 17, 2026 | 4 | Filing |
| Jul 17, 2026 | 3 | Filing |
| Jul 02, 2026 | 4 | Filing |
| Jul 02, 2026 | 4 | Filing |
| Jul 02, 2026 | 3 | Filing |
CONMED
| Country | United States |
| IPO Date | Jul 23, 1987 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 3,900 |
| CEO | Patrick J. Beyer |
Contact Details
11311 Concept Boulevard Largo,
Florida 33773 United States
Stock Details
| Ticker Symbol | CNMD |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000816956 |
| CUSIP Number | 207410101 |
| ISIN Number | US2074101013 |
| SIC Code | 3845 |
Recent News
- 4 days ago / zacks.comHere's Why You Should Retain CONMED Stock in Your Portfolio for Now
- 14 days ago / businesswire.comCONMED Corporation to Participate in the Jefferies Global Healthcare Conference
- 19 days ago / marketbeat.comCONMED Q3 Earnings Call Highlights
- 19 days ago / seekingalpha.comCONMED Corporation (CNMD) Q3 2026 Earnings Call Transcript
- 19 days ago / zacks.comConmed (CNMD) Q3 Earnings Top Estimates
- 19 days ago / zacks.comHere's What Key Metrics Tell Us About Conmed (CNMD) Q3 Earnings
- 1 month ago / gurufocus.comIs Conmed Corp (CNMD) a Bargain After 6.0% Drop? GF Value Says Undervalued
- 2 months ago / businesswire.comCONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026
- 3 months ago / zacks.comConmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?
- 3 months ago / businesswire.comCONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference
Add to Watchlist
Select watchlists to add or remove CNMD